Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SFXN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SGPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GREB1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC39A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PQLC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOLM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPCD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANXA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOCS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYBPC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDCL3P4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on